Clinical Trial Update: REported Outcomes in COPD With Trixeo in Real worlD in Germany

View source ↗

Summary

A real-world outcomes study of the COPD therapy Trixeo conducted in Germany has completed and reported outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trixeo

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED